Clinical Trial Update: Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain [Phase 3]

View source ↗

Summary

A Phase III study evaluating SL1002 for osteoarthritis of the knee is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• SL1002

Snippet

Sponsor: Saol Therapeutics Inc | Conditions: Osteoarthritis Knee Pain | Phase 3 | Status: RECRUITING